Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca partners with cooking website

AstraZeneca has entered into a partnership with Food University, a web-based culinary platform, to discuss healthy eating in support of the company's cholesterol drug Crestor

AstraZeneca (AZ) has entered into a partnership with Food University, a web-based culinary platform, to help educate consumers about healthy eating in support of the company's medication Crestor (rosuvastatin calcium), which is approved to lower cholesterol in combination with diet and exercise.

The partnership "aims to empower people to take control of their health by showing how even small changes, like incorporating more low-cholesterol foods into their diet, can make a big difference," the company said. "AstraZeneca hopes the information and tools provided through the Food University partnership will help people learn how to integrate healthy eating and cooking habits into their everyday routines."

Launched to coincide with National Nutrition Month in March, the partnership will include a video series in which Food University chefs provide cooking demonstrations and offer tips and recipes for healthy meals.

In addition, the recipes will be included from AZ's website for Crestor, which already offers visitors some healthy eating tools, including a seven-day, low-cholesterol meal planner.

Crestor, a "super-statin" launched in 2003, has been one of AstraZeneca's top-selling products, bringing in $4.5bn in 2009.

14th March 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics